Zehn Jahre AMNOG-Prozess aus Sicht der Onkologie: Neuland erschlossen, Bebauung geht weiter

por Bartol, Arne, Dreßler, Katrin, Kaskel, Peter, Landsberg, Christiane, Lechner, Cornelia, Petschulies, Marco
Publicado 2022

Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion

por Bartol, Arne, Dressler, Katrin, Kaskel, Peter, Landsberg, Christiane, Lechner, Cornelia, Petschulies, Marco
Publicado 2022

Evaluation of a cancer patient navigation program (“Onkolotse”) in terms of hospitalization rates, resource use and healthcare costs: rationale and design of a randomized, controll...

por Porzig, Ralf, Neugebauer, Sina, Heckmann, Thomas, Adolf, Daniela, Kaskel, Peter, Froster, Ursula G.
Publicado 2018

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

por Egerer, Gerlinde, Reichert, Dietmar, Pletz, Mathias W, Kaskel, Peter, Krobot, Karl J, Maertens, Johan
Publicado 2012

Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case

por Neugebauer, Sina, Griesinger, Frank, Dippel, Sabine, Heidenreich, Stephanie, Gruber, Nina, Chruscz, Detlef, Lempfert, Sebastian, Kaskel, Peter
Publicado 2022

Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting

por Kaskel, Peter, Tuschy, Silja, Wagner, Alexander, Bannert, Christian, Cornely, Oliver A., Glasmacher, Axel, Lipp, Hans-Peter, Ullmann, Andrew J.
Publicado 2007

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

por Wissing, Heimo, Ballus, Jose, Bingold, Tobias M, Nocea, Gonzalo, Krobot, Karl J, Kaskel, Peter, Kumar, Ritesh N, Mavros, Panagiotis
Publicado 2013

Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany

por Dabisch, Inna, Dethling, Jürgen, Dintsios, Charalabos-Markos, Drechsler, Melanie, Kalanovic, Daniel, Kaskel, Peter, Langer, Frank, Ruof, Jörg, Ruppert, Thorsten, Wirth, Daniel
Publicado 2014

Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)

por McArthur, Grant A., Mohr, Peter, Ascierto, Paolo Antonio, Arance, Ana, Banos Hernaez, Ana, Kaskel, Peter, Weichenthal, Michael, Shinde, Reshma, Stevinson, Kendall
Publicado 2017

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

por Bröckelmann, Paul J., Müller, Horst, Gillessen, Sarah, Yang, Xiaoqin, Koeppel, Larissa, Pilz, Veronika, Marinello, Patricia, Kaskel, Peter, Raut, Monika, Fuchs, Michael, Borchmann, Peter, Engert, Andreas, von Tresckow, Bastian
Publicado 2021